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The cyclic mononucleotides cAMP and cGMP are potent
signaling molecules that exert profound effects on cellular
homeostasis. cAMP, which was originally identified by its
ability to cause breakdown of glycogen in response to
adrenaline, is produced by adenylyl cyclase, an enzyme first
characterized in 1958. It took another decade to establish
that cGMP and the enzyme responsible for its synthesis,
guanylyl cyclase, are also present in mammalian tissues. In
the rod and cone cells of the retina, cGMP plays a central
role in the visual signal transduction cascade by opening
ligand-gated ion channels in sensory neurons. cGMP is also
produced in response to hormones, such as nitric oxide and
atrial natriuretic peptide, which leads to the relaxation of
vascular smooth muscle and is thus important for regulation
of blood pressure [1].
Now, more than a decade after the first reported adenylyl
cyclase structures, two atomic structures of a guanylyl cyclase
catalytic core have been reported. The first describes a
cyanobacterial guanylyl cyclase from Synechocystis PCC6803
[2] and the second a eukaryotic guanylyl cyclase from the
green alga Chlamydomonas reinhardtii [3]. They provide a
fresh look at the molecular basis for nucleotide selectivity
and allosteric regulation in these important enzymes.
D Do om ma ai in n   a ar rc ch hi it te ec ct tu ur re e   a an nd d   r re eg gu ul la at ti io on n
Mammalian adenylyl and guanylyl cyclases belong to the
class III nucleotide cyclase family [4,5]. Atomic structures
of mammalian adenylyl cyclase [6-8] showed that the
catalytic core of class III cyclases consists of either a
homodimer or a heterodimer of homologous domains
that associate to form a wreath-like structure (Figure 1, top
left). One or two active sites are formed at the interface
between the domains. In mammalian adenylyl cyclases,
the catalytic core is composed of homologous domains
(C1 and C2) that form only one functional active site. The
non-functional active site is the binding site for the
activator forskolin, a well-known hypotensive agent.
Most mammalian adenylyl cyclases are large transmem-
brane proteins and subject to complex regulation, most
importantly through direct interactions with heterotrimeric
GTP-binding (G) proteins (Figure 2, left-hand side). In
contrast, mammalian guanylyl cyclases are modular recep-
tor enzymes: they exist as homo- or heterodimers with one
catalytic domain in each polypeptide chain, and their
activity can be modulated directly by hormones or other
factors that bind to their accessory domains (Figure 2, right-
hand side) [9].
A Ab bs st tr ra ac ct t
Cyclic guanosine monophosphate (cGMP) is a critical second messenger that regulates cardio-
vascular function and vision in humans. Two recent papers, including one in BMC Structural
Biology, have revealed atomic structures of the enzymes that catalyze the synthesis of cGMP
providing new clues about the molecular basis of substrate specificity and allosteric regulation
in nucleotide cyclases.
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Not surprisingly, the catalytic core of both the Synechocystis
Cya2 guanylyl cyclase (which has approximately 30%
sequence identity to mammalian adenylyl cyclase and
guanylyl cyclase isoforms) and the C. reinhardtii enzyme
(which has 40-50% sequence identity to mammalian
guanylyl cyclases) adopt the same wreath-like structure that
was described for adenylyl cyclase (Figure 1). What then can
be learned from these structures? Discrimination between
GTP and ATP among class III nucleotide cyclases is critical
for the fidelity of signaling by cGMP and cAMP. This
specificity is determined, at least in part, by a pair of active-
site residues (Glu and Cys) in guanylyl cyclases and their
counterparts (Lys and Asp) in adenylyl cyclases. For
example, when the guanylyl cyclase Glu-Cys pair is replaced
with a Lys-Asp pair, the guanylyl cyclase is converted into a
highly specific adenylyl cyclase [10,11]. Although the
adenylyl cyclase Lys-Asp pair interacts directly with the
purine base [7], it is not known for certain whether their
equivalents in guanylyl cyclases contribute to specificity in
the same manner.
Unfortunately, neither of the guanylyl cyclase structures
contains a bound ligand to help define the mechanism of
specificity in the active site. The C. reinhardtii enzyme [3]
contains the Glu-Cys pair typical of mammalian guanylyl
cyclases at their expected topological positions, but covalent
modification of the active-site cysteine (a consequence of
the conditions necessary for crystallization) precludes further
interpretation. Interestingly, the bacterial Cya2 guanylyl
cyclase [2] has a non-canonical Glu-Gly pair, with the
critical Glu side chain being supported by a third basic
residue, conserved as Arg or Lys in guanylyl cyclases. Un-
expectedly, guanylyl cyclase activity is reduced and adenylyl
cyclase activity increased when the Glu-Gly pair of Cya2 is
replaced by a Glu-Cys pair [2]. Thus, the specific features
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The nucleotide cyclase wreath-like structure and active-site conformation. Comparison of the C. reinhardtii guanylyl cyclase catalytic core (green)
with that of the C1:C2 domains of activated mammalian adenylyl cyclase (PDB ID: 1CJU; blue) bound to a nucleotide analog (shown as a stick
model). The two active sites of the guanylyl cyclase are found in a cleft formed at the interface of two identical subunits (top left). The two subunits
form a wreath-like structure, with active sites located at either end of the cleft (bottom left). The nucleotide analog marks the position of the single
functional adenylyl cyclase active site. The guanylyl cyclase structure is presumed to be in an inactive conformation: in the active state of the
nucleotide cyclases, it is expected that helix α1 (labeled in the right-hand panel) moves into the active site and toward helix α4 of the other subunit
of the dimer. The arrows in the right-hand panel indicate the conformational changes required to generate the active configuration. From Winger et
al. [3] Figure 4 (PDB 3ET6).
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P-loop Helix α1that help discriminate between ATP and GTP in class III
cyclases are likely to be complex and not universally
conserved. Indeed, the relatively nonspecific mycobacterial
Rv1900c adenylyl cyclase contains a non-canonical Asn-Asp
pair that seems to be completely dispensable for binding
nucleotides [12].
O On nc ce e   a a   w wr re ea at th h, ,   a al lw wa ay ys s   a a   w wr re ea at th h? ?
The molecular mechanism of mammalian adenylyl
cyclase activation has been elusive because there is as yet
no structure representing a physiologically relevant basal,
inactive state of the catalytic core (a C1:C2 heterodimer in
the absence of activating ligands). The structure of the C2
homodimer of adenylyl cyclase has been used as a
surrogate, but its conformation is probably influenced by
the presence of two molecules of forskolin, which is used
to stabilize the dimer interface, and the fact that it lacks a
C1 domain, which is required for catalytic activity [6].
The guanylyl cyclase structures provide new images of basal
conformations that may be more physiologically relevant.
The catalytic core of the Synechocystis guanylyl cyclase
enzyme [2] assumes a conformation most similar to
catalytically competent states of adenylyl cyclases [8,12],
although, surprisingly, it adopts a closed conformation that
apparently needs to open before nucleotides can access the
active site. This could represent a regulatory difference from
the C. reinhardtii guanylyl cyclase and mammalian cyclases.
The  C. reinhardtii guanylyl cyclase [3] adopts a
conformation similar to that of the adenylyl cyclase C2
homodimer structure, in that the α1 helix, which binds to
the β- and γ-phosphates of the nucleotide (Figure 1), is not
properly aligned with the rest of the active site. The structure
may therefore serve as a useful model for the inactive state
of mammalian cyclases. However, the fact that crystals
could not be obtained without covalent modification of
cysteines leaves open the possibility that this structure still
does not represent the true ground-state conformation.
In 2005, Tews et al. [13] described the active and inactive
structures of a pH-sensing mycobacterial class III adenylyl
cyclase. Importantly, this structure included the regulatory
domains of the enzyme. In the active state, the catalytic
domains assume the familiar wreath-like dimer. In the
inactive state, they adopt a dramatically different conforma-
tion in which they interact extensively with the regulatory
domains. Although this enzyme is more distantly related to
mammalian adenylyl cyclases than the two guanylyl
cyclases described here (approximately 23% identity) [2,3],
it highlights the fact that accessory domains, such as those
found in the two guanylyl cyclase enzymes and in
mammalian adenylyl cyclases, can have a dramatic impact
on the conformation of the catalytic core in its inactive state.
There is also evidence that the ground-state structures of
some class III nucleotide cyclases may consist simply of
loosely associated, and therefore minimally active, catalytic
domains. Although the C. reinhardtii guanylyl cyclase
enzyme [3] was a homodimer under all conditions tested (J
Winger, personal communication), the Cya2 catalytic core
exists in an equilibrium between monomeric, dimeric and
oligomeric forms [2]. Forskolin and G proteins are known
to dramatically enhance the affinity of the independently
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Schematic diagram of adenylyl and guanylyl cyclases. Mammalian adenylyl cyclases (left-hand side) are typically transmembrane proteins activated by
heterotrimeric G proteins. Mammalian guanylyl cyclases (right-hand side) are receptor enzymes directly activated by hormones, such as nitric oxide
(NO), or other factors that bind to its regulatory domains (for simplicity, the regulatory domains are not shown).
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GTP cGMPexpressed C1 and C2 domains of mammalian adenylyl
cyclase, and the Rv1900c adenylyl cyclase forms an
asymmetric homodimer in its unliganded state, with an
unusually open active-site cleft [12].
Obviously, more structures of class III nucleotide cyclases
are needed, especially of those that include regulatory
domains. Although interpretation of the molecular mecha-
nism of activation for nucleotide cyclases is somewhat
hindered by the conditions required to bring about their
crystallization, it is also possible that each class III enzyme
has evolved a distinct basal conformation that can take
optimal advantage of the regulatory inputs unique to that
enzyme. This would probably enhance the fidelity of
signaling when multiple cyclase isoforms are present.
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